Associations of Three-Dimensional Anthropometric Body Surface Scanning Measurements and Coronary Artery Disease

Background and Objectives: The relationship between three-dimensional (3D) scanning-derived body surface measurements and biomarkers in patients with coronary artery disease (CAD) were assessed. Methods and Methods: The recruitment of 98 patients with CAD confirmed by cardiac catheterization and 98 non-CAD patients were performed between March 2016 and December 2017. A health questionnaire on basic information, life style variables, and past medical and family history was completed. 3D body surface measurements and biomarkers were obtained. Differences between the two groups were assessed and multivariable analysis performed. Results: It was found that chest width (odds ratio [OR] 0.761, 95% confidence interval [CI] = 0.586–0.987, p = 0.0399), right arm length (OR 0.743, 95% CI = 0.632–0.875, p = 0.0004), waist circumference (OR 1.119, 95% CI = 1.035–1.21, p = 0.0048), leptin (OR 1.443, 95% CI = 1.184–1.76, p = 0.0003), adiponectin (OR 0.978, 95% CI = 0.963–0.994, p = 0.006), and interleukin 6 (OR 1.181, 95% CI = 1.021–1.366, p = 0.0254) were significantly associated with CAD. The combination of biomarker scores and body measurement scores had the greatest area under the curve and best association with CAD (area under the curve of 0.8049 and 95% CI = 0.7440–0.8657). Conclusions: Our study suggests that 3D derived body surface measurements in combination with leptin, adiponectin, and interleukin 6 levels may direct us to those at risk of CAD, allowing a non-invasive approach to identifying high-risk patients.

[1]  Michael T. Lu,et al.  Small whole heart volume predicts cardiovascular events in patients with stable chest pain: insights from the PROMISE trial , 2021, European Radiology.

[2]  Sira Yongchareon,et al.  Modelling of Chest Wall Motion for Cardiorespiratory Activity for Radar-Based NCVS Systems , 2020, Sensors.

[3]  Y. Ragino,et al.  The Role of Secretory Activity Molecules of Visceral Adipocytes in Abdominal Obesity in the Development of Cardiovascular Disease: A Review , 2020, Biomolecules.

[4]  N. Frangogiannis,et al.  The Role of the TGF-β Superfamily in Myocardial Infarction , 2019, Front. Cardiovasc. Med..

[5]  Toshio Tanaka,et al.  Interleukin (IL-6) Immunotherapy. , 2018, Cold Spring Harbor perspectives in biology.

[6]  R. Brook,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American Society of Hypertension : JASH.

[7]  O. Barbarash,et al.  Adipokine and Cytokine Profiles of Epicardial and Subcutaneous Adipose Tissue in Patients with Coronary Heart Disease , 2017, Bulletin of Experimental Biology and Medicine.

[8]  Mohamed Faisal Lutfi.  The physiological basis and clinical significance of lung volume measurements , 2017, Multidisciplinary Respiratory Medicine.

[9]  Y. Abed,et al.  Obesity can predict and promote systemic inflammation in healthy adults. , 2016, International journal of cardiology.

[10]  Chiu-fen Yang,et al.  Association of serum leptin levels with central arterial stiffness in coronary artery disease patients , 2016, BMC Cardiovascular Disorders.

[11]  S. Weisnagel,et al.  Fitness, adiposopathy, and adiposity are independent predictors of insulin sensitivity in middle-aged men without diabetes , 2016, Journal of Physiology and Biochemistry.

[12]  C. Mantzoros,et al.  The role of leptin in regulating bone metabolism. , 2015, Metabolism: clinical and experimental.

[13]  A. Keys,et al.  Indices of relative weight and obesity. , 2014, International journal of epidemiology.

[14]  W. Frishman,et al.  Inflammation and Atherosclerosis: A Review of the Role of Interleukin-6 in the Development of Atherosclerosis and the Potential for Targeted Drug Therapy , 2014, Cardiology in review.

[15]  P. Raggi,et al.  Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis. , 2014, Atherosclerosis.

[16]  Sang Min Park,et al.  Association between insulin resistance and bone mass in men. , 2014, The Journal of clinical endocrinology and metabolism.

[17]  D. Kim,et al.  Insulin is inversely associated with bone mass, especially in the insulin-resistant population: the Korea and US National Health and Nutrition Examination Surveys. , 2014, The Journal of clinical endocrinology and metabolism.

[18]  Christopher J. L. Murray,et al.  Temporal Trends in Ischemic Heart Disease Mortality in 21 World Regions, 1980 to 2010: The Global Burden of Disease 2010 Study , 2013, Circulation.

[19]  L. El-Kadre,et al.  Interleukin-6 and obesity: the crosstalk between intestine, pancreas and liver , 2013, Current opinion in clinical nutrition and metabolic care.

[20]  S. Kihara,et al.  Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. 1999. , 2012, Biochemical and biophysical research communications.

[21]  J. Manson,et al.  Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women. , 2011, Atherosclerosis.

[22]  Xiping Xu,et al.  Percent Fat Mass Is Inversely Associated With Bone Mass and Hip Geometry in Rural Chinese Adolescents , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  Xinliang Ma,et al.  Protective vascular and myocardial effects of adiponectin , 2009, Nature Clinical Practice Cardiovascular Medicine.

[24]  Mark Woodward,et al.  Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. , 2008, Journal of clinical epidemiology.

[25]  G. Sweeney,et al.  Cardiac remodeling in obesity. , 2008, Physiological reviews.

[26]  A. Xu,et al.  Vascular effects of adiponectin: molecular mechanisms and potential therapeutic intervention. , 2008, Clinical science.

[27]  M. Hamrick,et al.  Is adiposity advantageous for bone strength? A peripheral quantitative computed tomography study in late adolescent females. , 2007, The American journal of clinical nutrition.

[28]  C. Berne,et al.  Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. , 2007, The Journal of clinical endocrinology and metabolism.

[29]  C. Meisinger,et al.  Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. , 2006, Journal of the American College of Cardiology.

[30]  Richard L. Jones,et al.  The effects of body mass index on lung volumes. , 2006, Chest.

[31]  Kohjiro Ueki,et al.  Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. , 2006, The Journal of clinical investigation.

[32]  W. Chiou,et al.  Waist-to-thigh ratio can also be a better indicator associated with type 2 diabetes than traditional anthropometrical measurements in Taiwan population. , 2006, Annals of epidemiology.

[33]  D. Yellon,et al.  Leptin, the obesity‐associated hormone, exhibits direct cardioprotective effects , 2006, British journal of pharmacology.

[34]  Paul Poirier,et al.  Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss: An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism , 2006, Circulation.

[35]  S. Kritchevsky,et al.  Low subcutaneous thigh fat is a risk factor for unfavourable glucose and lipid levels, independently of high abdominal fat. The Health ABC Study , 2005, Diabetologia.

[36]  W. Roberts.  CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice Laboratory Tests Available to Assess Inflammation— Performance and Standardization A Background Paper , 2004, Circulation.

[37]  Wen-Ko Chiou,et al.  The 3D scanner for measuring body surface area: a simplified calculation in the Chinese adult. , 2003, Applied ergonomics.

[38]  U. Das.  Is obesity an inflammatory condition? , 2001, Nutrition.

[39]  F. Luscinskas,et al.  MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions , 1999, Nature.

[40]  A Tremblay,et al.  Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. , 1990, Arteriosclerosis.

[41]  P. Björntorp.  Abdominal obesity and the development of noninsulin-dependent diabetes mellitus. , 1988, Diabetes/metabolism reviews.

[42]  D. Reed,et al.  CENTRAL OBESITY AND CORONARY HEART DISEASE IN MEN , 1987, The Lancet.

[43]  F. Cambien,et al.  The pattern of subcutaneous fat distribution in middle-aged men and the risk of coronary heart disease: the Paris Prospective Study. , 1986, International journal of obesity.

[44]  P. Björntorp,et al.  Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. , 1984, British medical journal.

[45]  A. Kissebah,et al.  Relation of Body Fat Distribution to Metabolic Complications of Obesity , 1982 .